Tag: Daiichi Sankyo

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Daiichi Sankyo

AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug - STAT News

Added to Collection on: 2025-01-19 17:17:50

Tags for this article:

Antibody-drug conjugates
Hereditary cancers
Daiichi Sankyo
Breast cancer
Deruxtecan
AstraZeneca
Heroin

Click the tags to see associated articles and topics

View Article Details
Antibody Drug Conjugates Market Size is Expected to Reach - GlobeNewswire

Added to Collection on: 2025-01-22 16:09:30

Tags for this article:

Antibody-drug conjugates
Biotechnology
Immunology
Monoclonal antibodies
Antibody-drug conjugate
Seagen
Brentuximab vedotin
ImmunoGen
Daiichi Sankyo
AstraZeneca
Cofetuzumab pelidotin
Antibody-oligonucleotide conjugate
United States

Click the tags to see associated articles and topics

View Article Details
Breaking frontiers with multidisciplinary cancer research - Nature

Added to Collection on: 2025-01-30 17:12:15

Tags for this article:

AstraZeneca
Medical research
Södertälje Municipality
Pfizer
Daiichi Sankyo
Fresenius
OWKIN

Click the tags to see associated articles and topics

View Article Details
Boost to Enhertu's prospects as FDA clears Roche diagnostic - pharmaphorum

Added to Collection on: 2025-02-02 21:10:02

Tags for this article:

Orphan drugs
Antibody-drug conjugates
Immunology
Antineoplastic drugs
Cancer treatments
Trastuzumab deruxtecan
HER2
Trastuzumab
Antibody-drug conjugate
Breast cancer
Pertuzumab
Dalpiciclib
Roche Diagnostics
Daiichi Sankyo

Click the tags to see associated articles and topics

View Article Details
Antibody Drug Conjugates Market Growth, Trends & Forecast - openPR.com

Added to Collection on: 2025-02-25 13:30:42

Tags for this article:

Immunology
Biotechnology
Antibody-drug conjugate
Genetic engineering
Seagen
Sutro Biopharma
Daiichi Sankyo
Antibody

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU - TipRanks.com

Added to Collection on: 2025-02-28 15:56:32

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
AstraZeneca
HER2
Durvalumab
Trastuzumab
Breast cancer
Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details
AstraZeneca breast cancer therapy wins recommendation for EU approval - Morningstar

Added to Collection on: 2025-02-28 15:37:57

Tags for this article:

Antibody-drug conjugates
Orphan drugs
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
Breast cancer
HER2
AstraZeneca
Trastuzumab
Antibody-drug conjugate
Dalpiciclib
TOKYO
AstraZeneca plc
Daiichi Sankyo Co Ltd

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU | Markets Insider

Added to Collection on: 2025-02-28 14:37:34

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
HER2
AstraZeneca
Durvalumab
Trastuzumab
Breast cancer
Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details
Emerging importance of HER3 in tumorigenesis and cancer therapy - Nature

Added to Collection on: 2025-03-14 19:07:09

Tags for this article:

AstraZeneca
Medical research
Södertälje Municipality
Research and development in the United States
Daiichi Sankyo
Astellas Pharma
AbbVie
Pfizer
Novartis
BLUEPRINT MEDICINES
Black Diamond Therapeutics
cullinan oncology

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo Push Enhertu to Frontline Breast Cancer With Phase III Data

Added to Collection on: 2025-04-22 12:36:11

Tags for this article:

Antineoplastic drugs
Immunology
Antibody-drug conjugates
Orphan drugs
Daiichi Sankyo
Trastuzumab deruxtecan
Antibody-drug conjugate
Pertuzumab
AstraZeneca
HER2
Trastuzumab
Breast cancer

Click the tags to see associated articles and topics

View Article Details
Book a Demo